Leith Rankine1,2, Ziyi Wang1, Elianna Bier1, Christopher Kelsey3, Shiva Das2, Lawrence Marks2, and Bastiaan Driehuys1
1Center for In Vivo Microscopy, Duke University, Durham, NC, United States, 2Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC, United States, 3Department of Radiation Oncology, Duke University Medical Center, Durham, NC, United States
Synopsis
Radiation therapy (RT) is widely used to treat lung cancer, but
damage to surrounding healthy tissues can lead to compromised lung function. In
this study, patients undergoing RT were imaged pre- and post-treatment using hyperpolarized
129Xe gas exchange MRI to assess for RT-induced changes in regional
lung function. At 3-months post-treatment, a dose-response was evident in
ventilation and gas exchange. Lung regions receiving ≥20Gy exhibited
significantly increased barrier uptake and decreased RBC transfer. This may
help radiation oncologists further understand the dose-dependence of RT-induced
lung injury, and design dose distributions with fewer treatment toxicities.
Introduction
Approximately 100,000 US patients
per year undergo radiation therapy (RT) for lung cancer. While RT improves tumor
control and survival, it also risks causing radiation-induced lung injury1 (RILI). Approximately 5-50%
of patients who receive conventional thoracic RT develop acute clinically
significant radiation pneumonitis (RP), presenting as fever, congestion,
persistent cough, and dyspnea; an estimated 2% of these patients die2,3. Subsequent late effects can
manifest as lung fibrosis, permanently reducing pulmonary function and quality
of life. Currently, predicting whether a specific patient’s treatment plan will
cause significant lung injury is challenging4, due in part to the inability
to regionally measure damage to lung
tissue. The ability to map and quantify such functional changes as a function
of radiation dose could enable better prediction and prevention of RILI. To
address this, we obtained pre- and post-RT hyperpolarized (HP)-129Xe
gas exchange MRI in patients being treated for non-small cell lung cancer
(NSCLC).Methods
Six patients receiving conventional RT for NSCLC underwent
breath-hold HP-¹²⁹Xe gas exchange MRI. Subjects were imaged pre- and 3-months
post-RT, with two subjects also imaged at 6-months post-RT. As previously
established5,6, gas exchange MRI exploits the
solubility and chemical shift of ¹²⁹Xe to permit 3D imaging of its distribution
into the lung airspaces (ventilation), uptake in the interstitial barrier
tissues, and its transfer to red blood cells (RBC). A breath-hold 3D radial 1H
image is also acquired to confine analysis to the thoracic cavity. The
gas-phase image is normalized by its top 1% of signal to map regional
ventilation; voxel-wise signal ratios of 129Xe barrier/gas map
interstitial barrier uptake, while RBC/gas measures end-to-end function (RBC transfer). The patients’ RT planning CT scans were registered to the pre-treatment anatomical ¹H MRI using a commercial deformable
algorithm (RaySearch Laboratories, Stockholm, Sweden). This allows the radiation dose distribution to be
transferred into the MR frame of reference. Each post-treatment MRI was rigidly
registered to the subject’s pre-treatment MRI to enable calculation of functional
change on a per-voxel basis. Spatial registration uncertainty was partly accounted for
by smoothing the functional images using a Gaussian filter (FWHM=6.25mm). Voxels
excluded from analysis were those with high dose gradient (≥3Gy/mm), those receiving
≥95% of prescription dose, and those with ventilated xenon signal <2σnoise
above background. Voxels receiving similar dose (within 5Gy) were binned and data
from all subjects was combined to plot radiation dose vs. mean functional
change for ventilation, barrier uptake, and RBC transfer. Functional changes at
3-months were compared in lung receiving <20Gy vs ≥20Gy using paired
t-tests, where 20Gy represents a standard threshold for potential lung damage
in conventional lung RT1.Results
Figures 1 and 2 show two representative patients with their dose
distributions and functional change maps. Key features include: prominently
increased barrier uptake in the left lung of Figure 1; mildly increasing
barrier uptake at both post-RT time points in Figure 2; and complex behavior of
the RBC transfer in Figure 2 (an apparent decrease at 3-months, followed by an
increase at 6-months). Across the patient ensemble, Figure 3 demonstrates that ventilation
decreases with dose for both time-points. At 3-months, average relative
ventilation increased by 1.6% in <20Gy voxels and decreased by 2% in the
≥20Gy voxels (P<0.08). Figure 4 shows that above a ~15-20Gy threshold, barrier
uptake increases at both 3- and 6-months. At 3-months, average barrier uptake in
≥20Gy voxels increased by 27%, compared to just 3% in <20Gy voxels (P<0.02;
percentages represent the change in barrier/gas divided by the healthy
reference mean barrier/gas). The effect of RT on RBC transfer was
more complex, showing a decrease at 3-months above ~35-40Gy, but increasing in
high-dose regions at 6-months (Figure 5). At 3-months, RBC
transfer decreased by 7% in ≥20Gy voxels while increasing by 2% in <20Gy voxels
(P<0.03; percentages are again relative to the healthy reference mean).Discussion
The observed increase in barrier uptake is consistent with
the known inflammatory nature of early stage RILI2. Similarly, decreasing RBC transfer
at 3-months for high-dose voxels suggests reduced regional function. Previous studies
using nuclear medicine approaches demonstrated dose-dependent reductions in
regional perfusion and, to a lesser degree, regional ventilation.7 The magnitude and volume of
these reductions were related to decline in global lung function8 (pulmonary function tests and
symptoms). Our dose-response trend in 129Xe-MRI ventilation agrees
with this previous work. We note that the 129Xe-MRI measures of barrier
uptake and RBC transfer are new and unique metrics that have not been previously
investigated in RT patients. Although they do not measure the exact same physiological
process, our 3-month trend for RBC transfer agrees with prior perfusion studies; however, our 6-month results deviated from the expected change in perfusion.Conclusion
Hyperpolarized-¹²⁹Xe MRI detects RT-induced, dose-dependent
changes in regional lung function. Future work, in concert with prior perfusion
and ventilation studies, may enhance our understanding of the physiology of
RT-induced lung injury. These methods could be applied to larger cohorts and
longitudinal studies, relating the observed functional changes to global lung
function decline and RILI symptoms. In addition, understanding the regional functional
sensitivity of lung tissue to radiation could inform RT treatment planning optimization9,10 and reduce the rate of RT-associated
lung injury. Acknowledgements
This
work was supported in part by National Institutes of Health (NIH) grant R01HL105643References
1. Marks LB, Bentzen SM, Deasy JO, et al.
Radiation Dose–Volume Effects in the Lung. Int J Radiat Oncol.
2010;76(3):S70-S76.
2. Mehta V. Radiation pneumonitis and
pulmonary fibrosis in non–small-cell lung cancer: Pulmonary function,
prediction, and prevention. Int J Radiat Oncol. 2005;63(1):5-24.
3. Ohe Y. Treatment-related death from
chemotherapy and thoracic radiotherapy for advanced cancer. Panminerva Med.
2002;44(3):205-212.
4. Das SK, Zhou S, Zhang J, et al. Predicting Lung Radiotherapy-Induced Pneumonitis Using a
Model Combining Parametric Lyman Probit With Nonparametric Decision Trees. Int
J Radiat Oncol. 2007;68(4):1212-1221.
5. Wang Z, Robertson SH, Wang J, et al.
Quantitative analysis of hyperpolarized 129Xe gas transfer MRI. Med Phys.
2017;44(6):2415-2428.
6. Kaushik SS, Robertson SH, Freeman MS,
et al. Single-breath clinical imaging of hyperpolarized 129Xe in the
airspaces, barrier, and red blood cells using an interleaved 3D radial 1-point
Dixon acquisition. Magn Reson Med. 2016;75(4):1434-1443.
7. Boersma LJ, Damen EMF, de Boer RW, et
al. Dose-effect relations for local functional and structural changes of the
lung after irradiation for malignant lymphoma. Radiother Oncol.
1994;32(3):201-209.
8. Boersma LJ, Damen EMF, de Boer RW, et
al. Estimation of overall pulmonary function after irradiation using
dose-effect relations for local functional injury. Radiother Oncol.
1995;36(1):15-23.
9. McGuire SM, Zhou S, Marks LB, et al. A methodology for using SPECT to reduce intensity-modulated
radiation therapy (IMRT) dose to functioning lung. Int J Radiat Oncol.
2006;66(5):1543-1552.
10. Yamamoto T, Kabus S, Bal M, et al. The first patient treatment of computed tomography
ventilation functional image-guided radiotherapy for lung cancer. Radiother
Oncol. 2016;118(2):227-231.